World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
77
Citations
23350
World Ranking
1813
National Ranking
891

Medicine

D-Index
78
Citations
23901
World Ranking
17990
National Ranking
8967

Overview

Paul J. Utz is affiliated with Stanford University in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with notable work in subfields such as Immunology, Molecular Biology, Infectious Diseases, Rheumatology, and Genetics.

Their published research covers several main topics, including:

  • T-cell and B-cell Immunology
  • Systemic Lupus Erythematosus Research
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Immune responses and vaccinations
  • Diabetes and associated disorders

Paul J. Utz has a significant portfolio of recent publications. Some of their notable papers include:

  • Systems vaccinology of the BNT162b2 mRNA vaccine in humans (2021, Nature)
  • Notch signalling drives synovial fibroblast identity and arthritis pathology (2020, Nature)
  • New-onset IgG autoantibodies in hospitalized patients with COVID-19 (2021, Nature Communications)
  • The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination (2021, Cell)
  • KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 (2022, Science)

The scientist frequently publishes in venues including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • JCI Insight
  • Nature
  • Science Translational Medicine

Paul J. Utz collaborates regularly with several coauthors, among whom the most frequent include:

  • Judith A. James
  • Joel M. Guthridge
  • Purvesh Khatri
  • Kari C. Nadeau
  • Holden T. Maecker

Best Publications

  • Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

    Seng Ryong Woo;Meghan E Turnis;Monica V Goldberg;Jaishree Bankoti

  • Identification of a putative regulator of early T cell activation genes

    Jeng-Pyng Shaw;P. J. Utz;D. B. Durand;J. J. Toole

  • Autoantigen microarrays for multiplex characterization of autoantibody responses

    William H. Robinson;Carla DiGennaro;Wolfgang Hueber;Brian B. Haab

  • RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination

    Adam G W Matthews;Alex J. Kuo;Santiago Ramón-Maiques;Sunmi Han

  • Systems vaccinology of the BNT162b2 mRNA vaccine in humans.

    Prabhu S. Arunachalam;Madeleine K. D. Scott;Thomas Hagan;Thomas Hagan;Chunfeng Li

  • New-onset IgG autoantibodies in hospitalized patients with COVID-19.

    Sarah Esther Chang;Allan Feng;Wenzhao Meng;Sokratis A Apostolidis

  • Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia

    Steven M. Chan;Andrew P. Weng;Robert Tibshirani;Jon C. Aster;Jon C. Aster

  • Single-Cell Chromatin Modification Profiling Reveals Increased Epigenetic Variations with Aging

    Peggie Cheung;Francesco Vallania;Hayley C. Warsinske;Michele Donato

  • KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19

    Unknown

  • Proteins Phosphorylated during Stress-induced Apoptosis Are Common Targets for Autoantibody Production in Patients with Systemic Lupus Erythematosus

    Paul J. Utz;Maria Hottelet;Peter H. Schur;Paul Anderson

  • Antigen microarray profiling of autoantibodies in rheumatoid arthritis.

    Wolfgang Hueber;Wolfgang Hueber;Brian A. Kidd;Brian A. Kidd;Beren H. Tomooka;Beren H. Tomooka;Byung J. Lee;Byung J. Lee

  • Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.

    William H. Robinson;Paulo Fontoura;Byung J. Lee;Henry E Neuman De Vegvar;Henry E Neuman De Vegvar

  • Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling

    Dan Levy;Alex J Kuo;Yanqi Chang;Uwe Schaefer

  • The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.

    Rita M. Tavares;Rita M. Tavares;Emre E. Turer;Chih L. Liu;Rommel Advincula

  • Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens.

    Paul J. Utz;Paul Anderson

  • Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range

    Scott M. Tabakman;Lana Lau;Joshua T. Robinson;Jordan Price

  • The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.

    Florian Wimmers;Michele Donato;Alex Kuo;Tal Ashuach

  • Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis

    Ricardo T. Paniagua;Orr Sharpe;Peggy P. Ho;Steven M. Chan

  • Protein microarrays for multiplex analysis of signal transduction pathways

    Steven M Chan;Joerg Ermann;Leon Su;C Garrison Fathman

  • Death, autoantigen modifications, and tolerance

    Paul J. Utz;Timothy J Gensler;Paul G. Anderson

  • Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules

    P J Utz;P Anderson

  • Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.

    Hideki Garren;William H. Robinson;Eva Krasulová;Eva Havrdová

Frequent Co-Authors

William H. Robinson
William H. Robinson Stanford University
Lawrence Steinman
Lawrence Steinman Stanford University
Mark M. Davis
Mark M. Davis Stanford University
Purvesh Khatri
Purvesh Khatri Stanford University
Judith A. James
Judith A. James Oklahoma Medical Research Foundation
C. Garrison Fathman
C. Garrison Fathman Stanford University
Mark C. Genovese
Mark C. Genovese Stanford University
Holden T. Maecker
Holden T. Maecker Stanford University
Or Gozani
Or Gozani Stanford University
Hongjie Dai
Hongjie Dai University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare fields, especially nursing. For professionals aiming to deepen their expertise, transitioning through specialized programs is essential. For instance, an fnp to acnp bridge program online offers nurse practitioners a pathway to specialize in acute care, which can complement immunology knowledge perfectly.

For those looking to fast-track their nursing career, accelerated np programs provide an intensive education route designed for quicker entry into advanced nursing roles. These programs are particularly useful for students eager to integrate immunology with clinical practice.

Non-nurses interested in healthcare can begin their journey through online adn programs for non nurses. These accessible options open doors to nursing fundamentals, which form a solid foundation for immunology-related careers.

Moreover, those seeking a smoother admission process might consider the easiest absn program to get into. These programs offer a user-friendly entry point for accelerated Bachelor of Science in Nursing degrees, merging well with the demands of immunological studies.

Exploring these educational pathways can enhance career prospects in immunology and related healthcare fields, making it easier to find a specialized and rewarding career.

Best Scientists Citing Paul J. Utz

Trending Scientists

Recently Published Articles